Biblio

Export 421 results:
Author Keyword Title [ Type(Asc)] Year
Filters: Keyword is Alzheimer Disease  [Clear All Filters]
Journal Article
A. Madhavan, Schwarz, C. G., Duffy, J. R., Strand, E. A., Machulda, M. M., Drubach, D. A., Kantarci, K., Przybelski, S. A., Reid, R. I., Senjem, M. L., Gunter, J. L., Apostolova, L. G., Lowe, V. J., Petersen, R. C., Jack, C. R., Josephs, K. A., and Whitwell, J. L., Characterizing White Matter Tract Degeneration in Syndromic Variants of Alzheimer's Disease: A Diffusion Tensor Imaging Study., J Alzheimers Dis, vol. 49, no. 3, pp. 633-43, 2016.
O. Godefroy, Bakchine, S., Verny, M., Delabrousse-Mayoux, J. - P., Roussel, M., and Pere, J. - J., Characteristics of Alzheimer's Disease Patients with Severe Executive Disorders., J Alzheimers Dis, vol. 51, no. 3, pp. 815-25, 2016.
G. Novak, Fox, N., Clegg, S., Nielsen, C., Einstein, S., Lu, Y., Tudor, I. Cristina, Gregg, K., Di, J., Collins, P., Wyman, B. T., Yuen, E., Grundman, M., H Brashear, R., and Liu, E., Changes in Brain Volume with Bapineuzumab in Mild to Moderate Alzheimer's Disease., J Alzheimers Dis, vol. 49, no. 4, pp. 1123-34, 2016.
K. E. Melah, Lu, S. Yuan- Fu, Hoscheidt, S. M., Alexander, A. L., Adluru, N., Destiche, D. J., Carlsson, C. M., Zetterberg, H., Blennow, K., Okonkwo, O. C., Gleason, C. E., N Dowling, M., Bratzke, L. C., Rowley, H. A., Sager, M. A., Asthana, S., Johnson, S. C., and Bendlin, B. B., Cerebrospinal Fluid Markers of Alzheimer's Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer's Disease., J Alzheimers Dis, vol. 50, no. 3, pp. 873-86, 2016.
P. Buchhave, Minthon, L., Zetterberg, H., Wallin, A. K., Blennow, K., and Hansson, O., Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia., Arch Gen Psychiatry, vol. 69, no. 1, pp. 98-106, 2012.
A. Kimura, Yoshikura, N., Hayashi, Y., and Inuzuka, T., Cerebrospinal Fluid C-C Motif Chemokine Ligand 2 Correlates with Brain Atrophy and Cognitive Impairment in Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 2, pp. 581-588, 2018.
D. - W. Chen, Wang, J., Zhang, L. - L., Wang, Y. - J., and Gao, C. - Y., Cerebrospinal Fluid Amyloid-β Levels are Increased in Patients with Insomnia., J Alzheimers Dis, vol. 61, no. 2, pp. 645-651, 2018.
D. Renard, Wacongne, A., Ayrignac, X., Charif, M., Fourcade, G., Azakri, S., Le Floch, A., Bouly, S., Marelli, C., Arquizan, C., Hirtz, C., Gabelle, A., Thouvenot, E., and Lehmann, S., Cerebrospinal Fluid Alzheimer's Disease Biomarkers in Cerebral Amyloid Angiopathy-Related Inflammation., J Alzheimers Dis, vol. 50, no. 3, pp. 759-64, 2016.
M. A. Burguillos, Deierborg, T., Kavanagh, E., Persson, A., Hajji, N., Garcia-Quintanilla, A., Cano, J., Brundin, P., Englund, E., Venero, J. L., and Joseph, B., Caspase signalling controls microglia activation and neurotoxicity., Nature, vol. 472, no. 7343, pp. 319-24, 2011.
K. Ding, Tarumi, T., Zhu, D. C., Tseng, B. Y., Thomas, B. P., Turner, M., Repshas, J., Kerwin, D. R., Womack, K. B., Lu, H., C Cullum, M., and Zhang, R., Cardiorespiratory Fitness and White Matter Neuronal Fiber Integrity in Mild Cognitive Impairment., J Alzheimers Dis, vol. 61, no. 2, pp. 729-739, 2018.
M. Mäkelä, Paetau, A., Polvikoski, T., Myllykangas, L., and Tanskanen, M., Capillary amyloid-β protein deposition in a population-based study (Vantaa 85+)., J Alzheimers Dis, vol. 49, no. 1, pp. 149-57, 2016.
E. Aso, Andrés-Benito, P., Carmona, M., Maldonado, R., and Ferrer, I., Cannabinoid Receptor 2 Participates in Amyloid-β Processing in a Mouse Model of Alzheimer's Disease but Plays a Minor Role in the Therapeutic Properties of a Cannabis-Based Medicine., J Alzheimers Dis, vol. 51, no. 2, pp. 489-500, 2016.
H. Khodadadi, Salles, É. Lopes, Jarrahi, A., Costigliola, V., Khan, M. B., Yu, J. C., Morgan, J. C., Hess, D. C., Vaibhav, K., Dhandapani, K. M., and Baban, B., Cannabidiol Ameliorates Cognitive Function via Regulation of IL-33 and TREM2 Upregulation in a Murine Model of Alzheimer's Disease., J Alzheimers Dis, vol. 80, no. 3, pp. 973-977, 2021.
I. A. Clark and Vissel, B., Broader Insights into Understanding Tumor Necrosis Factor and Neurodegenerative Disease Pathogenesis Infer New Therapeutic Approaches., J Alzheimers Dis, vol. 79, no. 3, pp. 931-948, 2021.
H. - F. Wang, Wan, Y., Hao, X. - K., Cao, L., Zhu, X. - C., Jiang, T., Tan, M. - S., Tan, L., Zhang, D. - Q., Tan, L., and Yu, J. - T., Bridging Integrator 1 (BIN1) Genotypes Mediate Alzheimer's Disease Risk by Altering Neuronal Degeneration., J Alzheimers Dis, vol. 52, no. 1, pp. 179-90, 2016.
F. Guillot, Kemppainen, S., Lavasseur, G., Miettinen, P. O., Laroche, S., Tanila, H., and Davis, S., Brain-Specific Basal and Novelty-Induced Alternations in PI3K-Akt and MAPK/ERK Signaling in a Middle-Aged AβPP/PS1 Mouse Model of Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 4, pp. 1157-73, 2016.
A. Malishkevich, Marshall, G. A., Schultz, A. P., Sperling, R. A., Aharon-Peretz, J., and Gozes, I., Blood-Borne Activity-Dependent Neuroprotective Protein (ADNP) is Correlated with Premorbid Intelligence, Clinical Stage, and Alzheimer's Disease Biomarkers., J Alzheimers Dis, vol. 50, no. 1, pp. 249-60, 2016.
I. Koychev, Jansen, K., Dette, A., Shi, L., and Holling, H., Blood-Based ATN Biomarkers of Alzheimer's Disease: A Meta-Analysis., J Alzheimers Dis, vol. 79, no. 1, pp. 177-195, 2021.
T. Dziedzic, Pera, J., Klimkowicz-Mrowiec, A., Mroczko, B., and Slowik, A., Biochemical and Radiological Markers of Alzheimer's Disease Progression., J Alzheimers Dis, vol. 50, no. 3, pp. 623-44, 2016.
A. Mulak, Bile Acids as Key Modulators of the Brain-Gut-Microbiota Axis in Alzheimer's Disease., J Alzheimers Dis, vol. 84, no. 2, pp. 461-477, 2021.
K. Le Guennec, Tubeuf, H., Hannequin, D., Wallon, D., Quenez, O., Rousseau, S., Richard, A. - C., Deleuze, J. - F., Boland, A., Frebourg, T., Gaildrat, P., Campion, D., Martins, A., and Nicolas, G., Biallelic Loss of Function of SORL1 in an Early Onset Alzheimer's Disease Patient., J Alzheimers Dis, vol. 62, no. 2, pp. 821-831, 2018.
M. Ibarria, Alegret, M., Valero, S., Morera, A., Guitart, M., Cañabate, P., Moreno, M., Lara, S., Diego, S., Hernández, J., Tantinyá, N., Vera, M., Hernandez, I., Becker, J. T., Ruiz, A., Boada, M., and Tárraga, L., Beneficial Effects of an Integrated Psychostimulation Program in Patients with Alzheimer's Disease., J Alzheimers Dis, vol. 50, no. 2, pp. 559-66, 2016.
A. Tsugawa, Sakurai, S., Inagawa, Y., Hirose, D., Kaneko, Y., Ogawa, Y., Serisawa, S., Takenoshita, N., Sakurai, H., Kanetaka, H., Hirao, K., and Shimizu, S., Awareness of the COVID-19 Outbreak and Resultant Depressive Tendencies in Patients with Severe Alzheimer's Disease., J Alzheimers Dis, vol. 77, no. 2, pp. 539-541, 2020.
W. M. A. D. Bino Fernando, Rainey-Smith, S. R., Gardener, S. L., Villemagne, V. L., Burnham, S. C., S Macaulay, L., Brown, B. M., Gupta, V. Bala, Sohrabi, H. R., Weinborn, M., Taddei, K., Laws, S. M., Goozee, K., Ames, D., Fowler, C., Maruff, P., Masters, C. L., Salvado, O., Rowe, C. C., and Martins, R. N., Associations of Dietary Protein and Fiber Intake with Brain and Blood Amyloid-β., J Alzheimers Dis, vol. 61, no. 4, pp. 1589-1598, 2018.
M. E. Flanagan, Larson, E. B., Walker, R. L., C Keene, D., Postupna, N., Cholerton, B., Sonnen, J. A., Dublin, S., Crane, P. K., and Montine, T. J., Associations between Use of Specific Analgesics and Concentrations of Amyloid-β 42 or Phospho-Tau in Regions of Human Cerebral Cortex., J Alzheimers Dis, vol. 61, no. 2, pp. 653-662, 2018.

Pages